AIM ImmunoTech Inc.
AIM- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000946644
In the last 90 days, AIM ImmunoTech Inc. insiders filed 10 open-market purchases and 0 sales; 18 institutions reported holding it in 13F filings for Q2 2026, worth $325.6K in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 11, 2026
- $4.52M
- Insider buysLast 90 days, $39.3K in total
- 10
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, 0 vs. previous quarter
- 18
- 13F valueReported value at the end of Q2 2026
- $325.6K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $88.0K
- −48.2% year over year
- Net income, FY2025
- -$14.0M
- No comparable prior period
- Free cash flow, FY2025
- –
- No comparable prior period
- Revenue, Q3 FY2026
- $22.0K
- −15.4% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Net loss for FY2025: $14.0M (15861.4% of revenue).
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 1.00M
- Shares sold short
- Change
- −77.8K
- −7.2% vs. previous
- Days to cover
- 2.46
- At average daily volume
Superinvestors holding AIM, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding AIM at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by AIM ImmunoTech Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 12, 2026 (view filing)8:00 AM ET | Nov 10 | 2 days | Equels Thomas KCEO & President | PPurchase | +39.0K | $0.138 | +$5.38K | +15.3%293.1K after | |
| Nov 10, 2026 (view filing)10:07 AM ET | Nov 9 | 1 day | Equels Thomas KCEO & President | PPurchase | +31.3K | $0.162 | +$5.07K | +14.0%254.1K after | |
| Nov 9, 2026 (view filing)3:47 PM ET | Nov 6 | 3 days | Equels Thomas KCEO & President | PPurchase | +12.8K | $0.158 | +$2.01K | +6.1%222.8K after | |
| Nov 6, 2026 (view filing)1:58 PM ET | Nov 6 | Same day | Equels Thomas KCEO & President | PPurchase | +20.3K | $0.156 | +$3.17K | +10.7%210.0K after | |
| Oct 26, 2026 (view filing)12:12 PM ET | Oct 23 | 3 days | Equels Thomas KCEO & President | PPurchase | +31.7K | $0.16 | +$5.07K | +20.0%189.7K after | |
| Oct 23, 2026 (view filing)12:29 PM ET | Oct 22 | 1 day | Equels Thomas KCEO & President | PPurchase | +31.3K | $0.163 | +$5.09K | +24.6%158.1K after | |
| Sep 18, 2026 (view filing)8:30 AM ET | Sep 17 | 1 day | Equels Thomas KCEO & President | PPurchase | +24.0K | $0.208 | +$4.99K | +23.3%126.8K after | |
| Sep 17, 2026 (view filing)12:01 PM ET | Sep 16 | 1 day | Equels Thomas KCEO & President | PPurchase | +11.0K | $0.21 | +$2.31K | +12.0%102.8K after | |
| Sep 16, 2026 (view filing)9:15 AM ET | Sep 15 | 1 day | Equels Thomas KCEO & President | PPurchase | +22.0K | $0.221 | +$4.86K | +31.5%91.8K after | |
| Sep 15, 2026 (view filing)4:30 PM ET | Sep 14 | 1 day | Equels Thomas KCEO & President | PPurchase | +5.90K | $0.219 | +$1.29K | +9.2%69.8K after |
Top 10 13F holders, Q2 2026
See all 18 holdersThe largest institutional positions in AIM ImmunoTech Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Jane Street Group, LLC | 807,885 | $229.4K | 0.00% | +787,838+3,930.0% | Added |
| Virtu Financial LLC | 124,269 | $35.0K | 0.00% | +73,374+144.2% | Added |
| Morgan Stanley | 50,864 | $14.4K | 0.00% | +50,000+5,787.0% | Added |
| Geode Capital Management, LLC | 46,003 | $13.1K | 0.00% | +16,085+53.8% | Added |
| Goldman Sachs Group Inc | 32,444 | $9.21K | 0.00% | +32,444 | New |
| UBS Group AG | 28,931 | $8.22K | 0.00% | +28,930+2,893,000.0% | Added |
| Susquehanna International Group, LLP | 21,859 | $6.21K | 0.00% | +21,859 | New |
| Vanguard Fiduciary Trust Co | 17,519 | $4.97K | 0.00% | 00.0% | Unchanged |
| Ground Swell Capital, LLC | 12,222 | $3.47K | 0.00% | +12,222 | New |
| Tower Research Capital LLC (TRC) | 4,668 | $1.33K | 0.00% | 00.0% | Unchanged |
Holders of 5% or more of AIM
See all 1 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of AIM ImmunoTech Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Orca Capital AG | 13G | 9.90%1.79M shares | New | May 12, 20261 filing | May 12, 2026 | SEC |